NASHVILLE, Tenn. / Mar 28, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: HCA Healthcare, Inc. 1Q Earnings Release Call
When: Friday, April 21, 2023 at 9:00 am central (10:00 am eastern)
How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$429.54 |
| Daily Change: | 2.85 0.67 |
| Daily Volume: | 972,926 |
| Market Cap: | US$100.510B |
August 27, 2025 July 25, 2025 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
